PharmaCyte Biotech, Inc. (PMCB)

NASDAQ: PMCB · Real-Time Price · USD

0.6950

+0.0150 (2.21%)

At close: Mar 12, 2026, 4:00 PM EDT

0.6750

-0.0200 (-2.87%)

After-hours: Mar 12, 2026, 7:24 PM EDT

PharmaCyte Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 12, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Market Cap	7	8	17	2	2	1
Market Cap Growth	-40.31%	-50.55%	942.43%	1.57%	10.70%	5.15%
Enterprise Value	-13.15	-7.11	-21.27	-66.41	-83.79	-0.75
Last Close Price	0.70	1.24	2.12	2.92	2.33	27.43
PE Ratio	-	0.39	-1.18	-13.27	-0.29	-0.37
PB Ratio	0.13	0.16	0.62	0.02	0.02	0.22
P/TBV Ratio	0.11	0.18	0.74	0.78	0.01	0.20
P/FCF Ratio	-	-2.83	-7.92	-0.43	-0.39	-0.44
P/OCF Ratio	-	-2.83	-7.92	-0.43	-0.39	-0.44
EV/EBITDA Ratio	-	1.62	2.50	10.29	19.08	0.21
EV/EBIT Ratio	-	1.62	2.50	10.29	19.08	0.21
EV/FCF Ratio	-	2.39	9.89	17.50	20.35	0.22
Net Debt / Equity Ratio	-0.31	-0.30	-1.81	-0.94	-0.95	-0.33
Net Debt / EBITDA Ratio	3.40	3.55	5.89	10.54	19.45	0.61
Net Debt / FCF Ratio	2.92	5.22	23.32	17.93	20.74	0.66
Quick Ratio	17.01	6.60	6.76	115.99	121.24	3.04
Current Ratio	18.01	7.68	6.80	116.18	121.38	3.14
Return on Equity (ROE)	-2.59%	67.08%	0.59%	-5.31%	-8.78%	-60.35%
Return on Assets (ROA)	-7.90%	-7.61%	-12.79%	-7.88%	-8.96%	-53.39%
Return on Invested Capital (ROIC)	-12.40%	-19.32%	-128.61%	-140.80%	-97.64%	-82.84%
Return on Capital Employed (ROCE)	-8.38%	-8.36%	-13.61%	-7.94%	-9.09%	-61.33%
Earnings Yield	-102.31%	257.26%	-84.91%	-7.53%	-347.64%	-267.95%
FCF Yield	-	-35.34%	-12.63%	-232.09%	-255.84%	-229.11%
Buyback Yield / Dilution	25.97%	30.17%	165.48%	829.54%	-5428.46%	-323.23%

Updated Dec 18, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q